Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life. [electronic resource]
Producer: 20191230Description: 1163-1175 p. digitalISSN:- 1097-0142
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- pathology
- Cell Transformation, Neoplastic
- Cerebrovascular Disorders -- epidemiology
- Cost of Illness
- Endocrine System Diseases -- epidemiology
- Female
- Follow-Up Studies
- Glioma -- pathology
- Hearing Loss -- epidemiology
- Humans
- Infant
- Infant, Newborn
- Long Term Adverse Effects -- epidemiology
- Male
- Neoplasm Grading
- Neurocognitive Disorders -- epidemiology
- Neurosurgical Procedures
- Obesity -- epidemiology
- Progression-Free Survival
- Radiotherapy
- Retrospective Studies
- Scoliosis -- epidemiology
- Seizures -- epidemiology
- Spinal Cord Neoplasms -- pathology
- Survival Rate
- Vision Disorders -- epidemiology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.